Improving Epilepsy Programs, Services, and Outcomes through National Partnerships

 

The purpose of this program is to: Reduce the treatment gap (i.e., shortening the time to diagnosis, and increasing referral to specialty care) by improving professional education about epilepsy diagnosis, treatment, and management); Increase access to appropriate health care services, community resources, and self-management supports among people with epilepsy and their families; Improve the publics knowledge about, and attitudes toward, epilepsy to reduce epilepsy stigma; and Improve health, social participation, and quality of life for people with epilepsy.

General information about this opportunity
Last Known Status
Active
Program Number
93.850
Federal Agency/Office
Centers For Disease Control and Prevention, Department of Health and Human Services
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Authorization
This program is authorized under the sections 301(a) and 317(k)(2) of the Public Health Service Act, [42 U.S.C. 241(a) and 247b(k)(2), as amended]
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Reference posted NOFOs available on Grants.gov
Beneficiary Eligibility
Individual/Family Racial/ethnic minority groups People with disabilities Specialty group Children Adults Older adults Schools Health Professional Educational Professional Student/trainee Low income Moderate income Rural Urban Suburban Education (0-13+) Nonprofit groups
Credentials/Documentation
Not applicable.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is not applicable.
Application Procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Award Procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
Deadlines
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
From 90 to 120 days.
Appeals
Not applicable.
Renewals
From 120 to 180 days. Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
How are proposals selected?
Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
How may assistance be used?
Specific goals will be provided in a funding opportunity announcement. In general, assistance requested under this program will be used to: • Assure a competent health professional workforce. • Mobilize community partnerships to improve the delivery and coordination of epilepsy care. • Inform and educate people about epilepsy, and empower people with epilepsy and their caregivers. Funds may be used for costs associated with planning, organizing, implementing, and evaluating program elements related to the objectives identified in 050 above. Recipients may expend funds for reasonable policies, systems, and program purposes, including personnel, travel, supplies, and services (including contractual).
What are the requirements after being awarded this opportunity?
Reporting
Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award.
Auditing
Not applicable.
Records
In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Sheryl Heard
4770 Buford Hwy, NE,
Atlanta, GA 30341 US
slh3@cdc.gov
Phone: 7704882855
Website Address
http://www.cdc.gov
Financial Information
Account Identification
75-0943-0-1-550
Obligations
(Cooperative Agreements) FY 22$4,699,581.00; FY 23 est $4,699,314.00; FY 24 est $4,699,314.00; FY 21$4,698,890.00; FY 20$3,567,141.00; FY 19$3,917,341.00; FY 18$3,567,141.00; FY 17$3,525,691.00; FY 16$3,175,691.00; -
Range and Average of Financial Assistance
1 award expected for $3,200,000;
Regulations, Guidelines and Literature
Not applicable.
Examples of Funded Projects
Not applicable.

 



Federal Grants Resources